Transforming lives with stem cell medicine
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW aims to pave the way for future stem cell-based treatments as well as stimulate a new wave of global investment in stem cell medicine and technologies, and create highly skilled jobs in this advancing medical field.
reNEW has been made possible through a record stem cell medicine grant of up to €300 million over 10 years from the Novo Nordisk Foundation, an international philanthropic foundation based in Denmark, which focuses on medical treatment and research.
reNEW is a tripartite collaborative research Center between three internationally leading Institutions: The University of Copenhagen, Leiden University Medical Center and the Murdoch Children’s Research Institute.
To advance a new generation of effective and safe stem cell-based therapies built on an international collaborative network of excellence in targeted biomedical research.
To develop an international targeted research Center to deliver innovative stem cell driven therapies to transform the lives of people with incurable disease.
Pillars of reNEW research:
EXPLORE fundamental research questions and form the basis for new translational research projects.
reSOLVE the basis of disease using stem cell-derived human tissue models.
reBUILD damaged tissues using stem cell based cellular therapies and engineered tissues.
reWRITE the genome of stem cells to provide new cellular functions.
PREPARE the community for novel stem cell-based products by investigating the ethical, social, regulatory, and economic barriers.